Chugai Pharmaceutical Co., Ltd. (CHGCF)
OTCMKTS
· Delayed Price · Currency is USD
53.65
-1.76 (-3.18%)
At close: Dec 5, 2025
Chugai Pharmaceutical Balance Sheet
Financials in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 456,432 | 540,202 | 458,674 | 222,169 | 267,753 | 212,333 | Upgrade
|
| Short-Term Investments | 426,015 | 456,143 | 280,308 | 280,938 | 204,217 | 166,287 | Upgrade
|
| Cash & Short-Term Investments | 882,447 | 996,345 | 738,982 | 503,107 | 471,970 | 378,620 | Upgrade
|
| Cash Growth | 4.39% | 34.83% | 46.88% | 6.60% | 24.65% | 13.68% | Upgrade
|
| Accounts Receivable | 353,649 | 334,256 | 318,892 | 512,538 | 355,081 | 253,342 | Upgrade
|
| Other Receivables | 205 | 896 | 1,456 | 1,745 | 928 | 12 | Upgrade
|
| Receivables | 353,854 | 335,152 | 320,348 | 514,283 | 356,009 | 253,354 | Upgrade
|
| Inventory | 246,326 | 240,067 | 273,480 | 292,206 | 208,838 | 183,893 | Upgrade
|
| Prepaid Expenses | - | 23,013 | 21,827 | 18,770 | 17,301 | 14,997 | Upgrade
|
| Other Current Assets | 35,103 | 11,466 | 11,789 | 8,171 | 9,543 | 4,042 | Upgrade
|
| Total Current Assets | 1,517,730 | 1,606,043 | 1,366,426 | 1,336,537 | 1,063,661 | 834,906 | Upgrade
|
| Property, Plant & Equipment | 463,150 | 441,554 | 420,701 | 386,651 | 352,107 | 297,490 | Upgrade
|
| Long-Term Investments | - | 73,073 | 61,086 | 56,185 | 44,663 | 31,287 | Upgrade
|
| Other Intangible Assets | 34,164 | 17,868 | 19,860 | 25,141 | 21,974 | 23,880 | Upgrade
|
| Long-Term Deferred Tax Assets | 82,885 | 69,835 | 64,474 | 65,244 | 56,287 | 47,934 | Upgrade
|
| Other Long-Term Assets | 85,659 | - | - | - | 2 | 1 | Upgrade
|
| Total Assets | 2,183,588 | 2,208,373 | 1,932,547 | 1,869,758 | 1,538,694 | 1,235,498 | Upgrade
|
| Accounts Payable | 78,897 | 65,353 | 112,468 | 209,835 | 152,266 | 100,396 | Upgrade
|
| Accrued Expenses | - | 49,324 | 44,629 | 37,751 | 34,421 | 31,575 | Upgrade
|
| Current Portion of Leases | - | 6,365 | 6,975 | 6,434 | 6,550 | 6,649 | Upgrade
|
| Current Income Taxes Payable | 43,365 | 142,499 | 71,573 | 121,160 | 108,293 | 83,313 | Upgrade
|
| Current Unearned Revenue | - | 31 | 31 | 79 | 86 | 80 | Upgrade
|
| Other Current Liabilities | 145,161 | 26,785 | 52,541 | 48,471 | 25,806 | 14,057 | Upgrade
|
| Total Current Liabilities | 267,423 | 290,357 | 288,217 | 423,730 | 327,422 | 236,070 | Upgrade
|
| Long-Term Leases | - | 4,532 | 6,480 | 7,675 | 9,490 | 4,635 | Upgrade
|
| Pension & Post-Retirement Benefits | 4,378 | 3,935 | 3,146 | 3,311 | 2,945 | 2,282 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 4,551 | 5,076 | 5,787 | 7,086 | 7,614 | 9,166 | Upgrade
|
| Other Long-Term Liabilities | 17,129 | 2,974 | 3,337 | 3,569 | 3,206 | 3,342 | Upgrade
|
| Total Liabilities | 293,481 | 306,874 | 306,967 | 445,371 | 350,677 | 255,495 | Upgrade
|
| Common Stock | 73,202 | 73,202 | 73,202 | 73,202 | 73,202 | 73,202 | Upgrade
|
| Additional Paid-In Capital | 70,389 | 69,896 | 69,355 | 68,806 | 68,223 | 67,586 | Upgrade
|
| Retained Earnings | 1,753,016 | 1,746,934 | 1,488,738 | 1,293,352 | 1,054,050 | 849,093 | Upgrade
|
| Comprehensive Income & Other | -6,500 | 11,467 | -5,715 | -10,973 | -7,458 | -9,878 | Upgrade
|
| Total Common Equity | 1,890,107 | 1,901,499 | 1,625,580 | 1,424,387 | 1,188,017 | 980,003 | Upgrade
|
| Shareholders' Equity | 1,890,107 | 1,901,499 | 1,625,580 | 1,424,387 | 1,188,017 | 980,003 | Upgrade
|
| Total Liabilities & Equity | 2,183,588 | 2,208,373 | 1,932,547 | 1,869,758 | 1,538,694 | 1,235,498 | Upgrade
|
| Total Debt | - | 10,897 | 13,455 | 14,109 | 16,040 | 11,284 | Upgrade
|
| Net Cash (Debt) | 882,447 | 985,448 | 725,527 | 488,998 | 455,930 | 367,336 | Upgrade
|
| Net Cash Growth | 4.39% | 35.83% | 48.37% | 7.25% | 24.12% | 14.68% | Upgrade
|
| Net Cash Per Share | 536.23 | 598.82 | 440.92 | 297.20 | 277.12 | 223.29 | Upgrade
|
| Filing Date Shares Outstanding | 1,646 | 1,646 | 1,645 | 1,645 | 1,644 | 1,644 | Upgrade
|
| Total Common Shares Outstanding | 1,646 | 1,646 | 1,645 | 1,645 | 1,644 | 1,644 | Upgrade
|
| Working Capital | 1,250,307 | 1,315,686 | 1,078,209 | 912,807 | 736,239 | 598,836 | Upgrade
|
| Book Value Per Share | 1148.51 | 1155.56 | 988.01 | 865.88 | 722.50 | 596.16 | Upgrade
|
| Tangible Book Value | 1,855,943 | 1,883,631 | 1,605,720 | 1,399,246 | 1,166,043 | 956,123 | Upgrade
|
| Tangible Book Value Per Share | 1127.75 | 1144.70 | 975.94 | 850.59 | 709.13 | 581.63 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.